P/E ratio for SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation) (2070.SR)
P/E ratio as of May 2024 (TTM): -540
According to SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation)'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -539.879. At the end of 2022 the company had a P/E ratio of -15.9.
P/E ratio history for SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation) from 2013 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -15.9 | -108.87% |
| 2021 | 179 | 367.97% |
| 2020 | 38.2 | -609.62% |
| 2019 | -7.50 | -115.82% |
| 2018 | 47.4 | 80.35% |
| 2017 | 26.3 | 51.09% |
| 2016 | 17.4 | 59.27% |
| 2015 | 10.9 | -8.74% |
| 2014 | 12.0 | -36.39% |
| 2013 | 18.8 | 31.85% |
| 2012 | 14.3 | -4.27% |
| 2011 | 14.9 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.